Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis

Abstract Intravenous immunoglobulin (IVIg) is a first-line treatment for children with newly diagnosed immune thrombocytopenia (ITP). Higher doses of IVIg are associated with a more insupportable financial burden to pediatric patients’ families and may produce more adverse reactions. Whether low-dos...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Xiangge Ren, Miaomiao Zhang, Xiaohan Zhang, Peidong Zhao, Wensheng Zhai
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2024-03-01
Seri Bilgileri:	BMC Pediatrics
Konular:	Newly diagnosed immune thrombocytopenia Intravenous immunoglobulin Children Dose Meta-analysis
Online Erişim:	https://doi.org/10.1186/s12887-024-04677-3
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!